Literature DB >> 22284073

Evaluation of postmortem redistribution phenomena for commonly encountered drugs.

Eunyoung Han1, Eunmi Kim, Hyojeong Hong, Sujin Jeong, Jihyun Kim, Sangwhan In, Heesun Chung, Sangki Lee.   

Abstract

We described the findings of a study into the post-mortem redistribution (PMR) of 76 drugs found in 129 drug-related cases between 2006 and 2009. Seventy six drugs (psychotropic drugs (n=14), antidepressants (n=9), sedatives (n=6) and so on) were simultaneously quantified in cardiac and peripheral blood by gas chromatography-mass spectrometry (GC/MS) or liquid chromatography-tandem mass spectrometry (LC/MS/MS). The absence, possibility or presence of PMR of drugs was determined according to the ratios of cardiac to femoral blood concentrations (C/P ratios). Proxyphylline (C/P ratio: 0.85) showed no PMR; carbamazepine was not subject to PMR; a potential for PMR of lorazepam and mirtrazapine cannot be excluded; chlordiazepoxide is subject to PMR; acetaminophen and alprazolam exhibit minimal PMR; amitriptyline and benztropine exhibit PMR. Codeine (C/P ratio: 4.9), zolpidem (C/P ratio: 3.74), chlorpromazine (C/P ratio: 2.97), fluoxetine (C/P ratio: 2.83) and propranolol (C/P ratio: 2.72) had the largest C/P ratios. Postmortem drug concentrations showed variations depending on sampling sites and characteristics of the drugs. It is continuously necessary to analyze commonly used or abused drugs in simultaneously collected cardiac and peripheral blood to establish significant reference values for PMR. These findings can be used to reach a conclusion about the cause and manner of death.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284073     DOI: 10.1016/j.forsciint.2012.01.016

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  8 in total

1.  A suicide involving intraperitoneal injection of pentobarbital.

Authors:  Sarah Hangartner; Jasmin Steiner; Franz Dussy; Regula Moeckli; Kathrin Gerlach; Thomas Briellmann
Journal:  Int J Legal Med       Date:  2015-07-15       Impact factor: 2.686

2.  Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation.

Authors:  Jineane V Venci; Meghan M Rowcliffe; Lance Wollenberg; Michelle M Rainka; Fran M Gengo
Journal:  Forensic Sci Med Pathol       Date:  2012-08-23       Impact factor: 2.007

3.  Amitriptyline accumulation in tissues after coated activated charcoal hemoperfusion-a randomized controlled animal poisoning model.

Authors:  Tejs Jansen; Lotte C G Hoegberg; Thomas Eriksen; Kim P Dalhoff; Bo Belhage; Sys S Johansen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-11       Impact factor: 3.000

4.  Time-dependent postmortem redistribution of morphine and its metabolites in blood and alternative matrices-application of CT-guided biopsy sampling.

Authors:  Sandra N Staeheli; Dominic Gascho; Lars C Ebert; Thomas Kraemer; Andrea E Steuer
Journal:  Int J Legal Med       Date:  2016-12-03       Impact factor: 2.686

Review 5.  The clinical and forensic toxicology of Z-drugs.

Authors:  Naren Gunja
Journal:  J Med Toxicol       Date:  2013-06

6.  Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma.

Authors:  Terhi Launiainen; Ilkka Ojanperä
Journal:  Drug Test Anal       Date:  2013-07-23       Impact factor: 3.345

7.  Post-mortem oxycodone blood concentrations of hospitalized cancer and surgery patients compared with fatal poisonings.

Authors:  Pirkko Kriikku; Eija Kalso; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2022-09-06       Impact factor: 2.791

8.  Time- and temperature-dependent postmortem concentration changes of the (synthetic) cannabinoids JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol following pulmonary administration to pigs.

Authors:  Nadine Schaefer; Ann-Katrin Kröll; Christina Körbel; Matthias W Laschke; Michael D Menger; Hans H Maurer; Markus R Meyer; Peter H Schmidt
Journal:  Arch Toxicol       Date:  2020-03-18       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.